Regulatory Affairs Consultant

Specialized regulatory services across pharmaceuticals, medical devices, cosmetics, health foods, veterinary products, industrial and consumer goods.

Cisema is your trusted regulatory affairs consultant for China, Hong Kong, Taiwan, and Southeast Asia. With significant regulatory experience, we deliver customized regulatory strategy, authority communication, and full lifecycle management tailored to your product type and regulatory challenge. Whether launching drug applications, registering a medical device, or filing a cosmetic or health supplement, our regulatory affairs experts provide hands on support from submission to surveillance, ensuring successful market entry in key markets.

Market Access Consulting
Regulatory Affairs Consultant
Medical device clinical trial in China img

Regulatory Intelligence

In today’s fast-paced regulatory landscape, we keep our clients ahead by delivering timely regulatory intelligence. We continuously monitor and analyze regulatory changes, updates, and trends from regulatory agencies and regulatory authorities not only in the jurisdictions we specialize in but also worldwide. With our deep understanding of both global regulatory requirements and local requirements, we provide actionable insights that help companies anticipate potential challenges, adapt strategies, and maintain compliance. By taking this proactive approach, we not only support the development of effective regulatory strategies but also maximize approval success and minimize costly delays, ensuring our clients maintain a competitive edge.

Regulatory consulting

Pharmaceutical & Biotech Regulatory Services

The Asia Pacific region offers major opportunities for life sciences companies, but success requires more than global documentation. At Cisema, we provide tailored regulatory affairs consulting that combines regulatory intelligence, local expertise, and operational precision. From clinical trial applications to post-market lifecycle management, our experienced team reduces approval risks, ensures compliance with local requirements, and streamlines regulatory submissions to accelerate successful market entry across the region.

Regulatory Strategy & Planning

Regulatory classification and country-specific roadmap development
Local adaptation of global regulatory strategy
(Pre-) IND,s CTAs, (Pre-) NDAs, MAAs, BLAs, to DMF planning and submissions

Dossier Preparation & Submission Management

Full lifecycle document preparation and formatting
Submission management to NMPA and APAC authorities
Real-time engagement for regulatory submissions

CMC & GMP Support

Gap analysis and CMC documentation preparation
GMP readiness assessment and strategic support
Technology transfer and compliance alignment

Labeling & Promotional Compliance

Regulatory review of labeling and advertising
Language adaptation and warning statements
Compliance with promotional material guidelines

Local Representation

NMPA Legal Agent services
Liaison with regulatory agencies and domestic communications
Regulatory Consultants for Marketing Authorizations

Medical Device & IVD Regulatory Services

As a medical device regulatory affairs consultant, we help manufacturers align with regulatory requirements, achieve product approvals, and stay compliant throughout the regulatory pathway.

Product Registration & Classification

Device classification and advice on the best pathway to market
Registration documentation preparation
Country-specific registrations

Testing & Clinical Requirements

NMPA type testing with on-site engineer supervision
Clinical trials and clinical evaluations setup and management when required
Clinical Evaluation Report (CER) preparation

Combination Products

Pathway development for drug-device combinations
Determining lead component and regulatory submissions
Coordinated handling with regulatory authorities

Quality Compliance & PMS

Pre-inspection readiness support
Post-Market Surveillance (PMS) programs
Adverse event monitoring and reporting

Local Legal Representation

Legal Agent and Local Responsible Person in various jurisdictions throughout Asia Pacific including China, Hong Kong and Taiwan
Regulatory excellence for cosmetics companies

Cosmetic Regulatory Services

As a cosmetic regulatory affairs consultant, we help companies ensure compliance with regulatory requirements in both China and Taiwan.

Product Filing & Registration

China NMPA general and special cosmetic filing
Taiwan TFDA notification and unified system submissions
New cosmetic ingredient registration and CIC filings

Responsible Person Representation

Appointed RP for China and Taiwan
Certificate management and regulatory submissions

Labeling, Packaging, & Claims Review

INCI verification and efficacy claims review
Taiwan and China label compliance
Fair packaging checks

Cosmetic Testing & GMP Compliance

Microbiological, chemical, toxicological, and efficacy testing
Cosmetic GMP audits and QMS alignment
SOP drafting and documentation preparation

Post-Market Surveillance & Cosmetovigilance

Adverse event monitoring and risk classification
Reporting system setup and trend analysis
Health Food Regulatory Consultants

Health Food & Supplement Regulatory Services

We act as a health food regulatory affairs consultant, supporting product development and helping companies achieve market access while meeting regulatory requirements.

Regulatory Classification & Filing

Product classification (health food, functional food, general food)
Health food registration and notification
Functional claim verification

Label & Ingredient Compliance

Ingredient and formula review against IECIC
Functional claims catalogue checks
Label validation and country-of-origin declaration

Safety & Functional Testing

Nutrient verification
Toxicological and efficacy testing
Approved lab studies for product development

Responsible Agent & 
Post-Market Compliance

Legal agent services for health food
Ongoing compliance and surveillance support
Regulatory affairs consultant

Veterinary Medicines & Products

As a veterinary regulatory affairs consultant, we offer regulatory expertise for MARA and NMPA submissions to support marketing authorization of veterinary products.

Product Registration & Classification

Veterinary medicine registration with MARA
Feed additive filing and veterinary IVD approvals

Dossier and Safety Support

Registration dossier preparation and safety studies
Toxicology and residue coordination

Labeling & Authority Engagement

Label content review
Liaison with regulatory authorities
Industrial & Consumer Goods Regulatory Services

Industrial & Consumer Goods Regulatory Services

We deliver regulatory consulting for industrial and consumer goods, providing a flexible approach that supports global regulatory certifications and ongoing compliance.

Product Certification
& Testing

CCC, CEL, CCCF, SELO, HAF 604, RoHS, SRRC, NAL
Factory audits and performance testing

Labeling & Customs Compliance

Review of technical labels, manuals, and packaging
HS code classification and tariff advisory services

Legal Representation & Ongoing Compliance

Domestic agent services
Lifecycle management and monitoring of regulatory changes

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Market Access Consulting

Latest Insights

View More

China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 

China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

May 8, 2026
China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 
A young Asian woman in understated casual clothing holding a single unbranded boxed hair dye product slightly angled toward her as she studies the ingredient panel.

Hong Kong Launches Primary Evaluation Phase 1 for NDAs

Hong Kong introduces Primary Evaluation Phase 1 for NDAs, requiring pathway selection across 3 routes and reshaping drug registration strategy.

May 6, 2026
Hong Kong Launches Primary Evaluation Phase 1 for NDAs
A single Asian scientist in their 30s wearing a lab coat, safety glasses, and nitrile gloves seated at a tidy bench in a modern pharmaceutical laboratory in Hong Kong, calmly reviewing a few printed documents while referencing a simple laptop screen

Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138

Hong Kong confirms injectable products are generally classified as pharmaceutical products under Cap. 138, impacting medical aesthetics and borderline products

May 8, 2026
Hong Kong Clarifies Injectable Products Are Regulated as Pharmaceutical Products Under Cap. 138
Minimalist, well-lit medical aesthetics clinic in Hong Kong. An Asian female doctor in a simple white coat and disposable gloves sits beside a female patient, holding a single unbranded prefilled syringe at chest level.

China April 2026 Reforms Reshape Drug Approval, Pricing, & Access

The reforms introduce new drug pricing rules, clarified conditional approval procedures, and tiered care measures.

May 8, 2026
China April 2026 Reforms Reshape Drug Approval, Pricing, & Access
Chinese scientists gathered around a bottle of medicine

Taiwan Abolishes Legacy Cosmetics Review Fees

TFDA eliminates legacy cosmetics review fees, reducing compliance costs for foreign companies.

May 5, 2026
Taiwan Abolishes Legacy Cosmetics Review Fees
Team reviews cosmetics documents for regulatory compliance and market access in Taiwan

CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies

CMDE maps 275 guideline updates, tightening requirements and giving manufacturers early visibility for planning and compliance.

May 5, 2026
CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies
dermatology treatment room in a modern Chinese hospital, medium shot: a licensed clinician in medical scrubs and protective eyewear performing a laser skin procedure using a professional Nd:YAG laser system
Previous
Previous

Engage Our Regulatory Affairs Consultants

Whether your product is pharmaceutical, cosmetic, medical, or industrial, we help you meet all regulatory obligations across China and Asia Pacific.

Request Proposal